Vexim Aktie [WKN DE: A1J45H / ISIN: FR0011072602]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Vexim

14.02.18		Stryker Crosses The 95% Thresholds in VEXIM and Announces Its Intention to File a Proposed Public Buy-out Offer Followed by a Squeeze-out for the Outstanding Shares of VEXIM (Businesswire)
12.01.18		VEXIM: +17% Growth in Sales in 2017 up to €21.6 Million (Businesswire)
12.12.17		VEXIM Announces the Results of the Simplified Tender Offer Initiated by Stryker (Businesswire)
25.10.17		NASS 2017: VEXIM Cancels the Investor & Analyst Lunch Meeting and Webcast Scheduled on Wednesday, October 25th (Businesswire)
24.10.17		VEXIM to be Acquired by Stryker Corporation (Businesswire)
14.09.17		VEXIM: Strong First Half 2017 Results, in Line with Expectations (Businesswire)
13.09.17		VEXIM: Amendment of the Financial Agenda for 2017 (Businesswire)
19.01.17		VEXIM Strengthens its Management Team, Through the Appointment of Russell Powers as Vice President and General Manager for its US Business (Businesswire)
16.11.16		VEXIM Again Awarded « Fastest Growing Listed Company » in the 2016 Technology Fast 50 for Southwestern France by Deloitte In Extenso (Businesswire)
13.10.16		Vexim: +37% Sales Increase to €13.3 Million as of September 30, 2016 (9 Months) (Businesswire)
20.09.16		VEXIM: Strong First Half 2016 Results in Line with Expectations (Businesswire)
13.09.16		VEXIM Signs a Distribution Agreement with Creatori Health and Expands Its Market to South Africa (Businesswire)
02.09.16		Vexim: Amendment of the Financial Agenda for 2016 (Businesswire)
12.07.16		VEXIM: +40% Revenue Growth in the 1st Half 2016: Upper Range of Goals (Businesswire)
12.07.16		Vexim: Amendment of the Financial Agenda for 2016 (Businesswire)
28.06.16		Vexim: Publication of the Shareholders’ Newsletter – June 2016 (Businesswire)
09.06.16		Vexim Strengthens Its Executive Team with the Appointments of: Sébastien Lemoine as Vice-President International Sales and Market Development; François Cathelineau as Vice-President Operations (Businesswire)
14.04.16		VEXIM: Strong Revenue Growth in Q1 2016 (Businesswire)
23.03.16		VEXIM: 2015 Financial Results (Businesswire)
14.01.16		Strong growth of VEXIM’s sales during 2015: +34%, up to €14 million (Businesswire)
12.01.16		VEXIM Initiates a New Clinical Study to Support Safety, Efficacy and Cost-Effectiveness of SpineJack® Compared to Conservative Treatment (Businesswire)
07.01.16		VEXIM Exceeds the Threshold Of 25,000 SpineJack® Implants Sold (Businesswire)
10.12.15		VEXIM Presents Its Financial Agenda for 2016 (Businesswire)
30.11.15		Vexim Announces the Nomination of Steve Swinson as New Chairman of the Board of Directors (Businesswire)
04.11.15		VEXIM’s Excellent Performance Ranked in Technology Fast 50 for Southwestern France by Deloitte In Extenso (Businesswire)
21.10.15		Vexim to Attend Upcoming Investor Conferences in November and December 2015 (Businesswire)
13.10.15		Vexim Announces Strong Third Quarter 2015 Sales Results (Businesswire)
30.09.15		Vexim Announces 2015 Half-Year Results (Businesswire)
28.07.15		Vexim Announces 2015 First Half Sales Results (Businesswire)
11.06.15		VEXIM Strengthens His Management Team with the Appointment of Gunther Peeters as VP Sales Europe & Global Marketing, and Remco Maljers as VP Indirect Sales & Business Development (Businesswire)
04.06.15		VEXIM Initiates International Clinical Study with First Patient Treated to Support Planned 510(k) Application to Market SpineJack® in the United States (Businesswire)
12.05.15		VEXIM Announces the Publication of a Shareholders Newsletter (Businesswire)
20.04.15		VEXIM announces its participation in the Smallcap Event on April 27 and 28 in Paris (GlobeNewswire)
20.04.15		VEXIM Announces Its Participation in the Smallcap Event on April 27 and 28 in Paris (Businesswire)
17.04.15		Vexim Reports 1-year Results of Comparative Randomized Study of SpineJack® versus Balloon Kyphoplasty (Businesswire)
16.04.15		Vexim Announces 2015 First Quarter Sales Results (Businesswire)
24.03.15		VEXIM: 2014 Annual Results (Businesswire)
10.03.15		VEXIM Obtains CE Approval to Market MasterflowTM Injection System in Europe (Businesswire)
02.03.15		Excellent Long Term Performances of SpineJack® Supported by a 24-Month Follow-up Clinical Study (Businesswire)
19.02.15		VEXIM Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency (Businesswire)
12.02.15		VEXIM: Patents Are Now Granted in Europe, US and China for MASTERFLOW®, the New High-Performance Cement Delivery System (Businesswire)
02.02.15		VEXIM Announces the First Sales of its MasterflowTM Injection System in the United States (Businesswire)
26.01.15		VEXIM 2014 Sales Increase Sharply by 69% to €10.3 Million (Businesswire)
19.12.14		VEXIM Presents its Financial Agenda for 2015 (Businesswire)
10.12.14		VEXIM Obtains FDA Approval to Market MasterflowTM Injection System in the United States (Businesswire)
17.11.14		VEXIM joins the EnterNext© PEA-PME 150 index (Businesswire)
12.11.14		VEXIM Appoints National Sales Director for U.S. Market (Businesswire)
13.10.14		VEXIM to Initiate Clinical Study to Support Planned 510(k) Application to Market SpineJack® in the United States (Businesswire)
30.09.14		Vexim Reports Six Month Results of Comparative Study of SpineJack® versus Balloon Kyphoplasty (Businesswire)
22.09.14		VEXIM Announces Strong 2014 Half-year Results (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Bitcoin Kurs Prognose: Absturz auf 90.000 US-Dollar bereits diese Woche?

BYD-Aktie: CEO sieht Chinas Elektroautos als führend in der globalen Konkurrenz

Just Eat-Aktie steigt über 50%: Einigung mit Prosus auf Übernahme für Milliardenbetrag - Prosus-Aktie in Rot

Alibaba-Aktie gibt deutlich ab: Alibaba will Milliarden in Cloud und KI investieren

Apple-Aktie, Google-Aktie, NVIDIA-Aktie uneins: KI-Investitionspläne und mögliche EU-Kartellklage sorgen für Aktienbewegungen

Nach Wahl in Deutschland: Wall Street schließlich uneins -- ATX schließt im Plus -- DAX beendet Handel stärker -- Asiens Börsen letztlich leichter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	26.02.2025 12:15
Kaufwert:	EUR
	Hinzufügen Speichern